Goldman Sachs Raises Price Target on Teradyne (TER) to $350
On April 30, 2026, Goldman Sachs raised its price target for Teradyne (NASDAQ:TER) from $300 to $350 and maintained a Buy rating. The firm cited strong demand in semiconductor testing driven by AI-related growth drivers such as HBM and DRAM. Citi also increased its price target on TER to $400.
Topics: AI stocks Citi Goldman Sachs Semiconductor testing Teradyne